RadNet, Inc. Goodwill, Acquired During Period
RadNet, Inc. (RDNT) reported Goodwill, Acquired During Period of $218.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-08-10
- RadNet, Inc. goodwill, acquired during period for the quarter ending 2026-06-30 was $30.61M, a 9.33% increase year-over-year.
- RadNet, Inc. goodwill, acquired during period for the quarter ending 2026-03-31 was $188.00M, a 4636.84% increase year-over-year.
- RadNet, Inc. goodwill, acquired during period for the quarter ending 2025-12-31 was $79.85M, a 1912.30% increase year-over-year.
- RadNet, Inc. goodwill, acquired during period for the quarter ending 2025-09-30 was $76.43M.
- RadNet, Inc. goodwill, acquired during period for fiscal 2025 was $188.24M, a 442.52% increase from fiscal 2024.
- RadNet, Inc. goodwill, acquired during period for fiscal 2024 was $34.70M, a 436.03% increase from fiscal 2023.
- RadNet, Inc. goodwill, acquired during period for fiscal 2023 was $6.47M, a 96.18% decline from fiscal 2022.
- RadNet, Inc. goodwill, acquired during period for fiscal 2022 was $169.25M, a 314.17% increase from fiscal 2021.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $218.61M 10-Q · filed 2026-08-10 | $298.46M derived: sum of 3 quarters · filed 2026-08-10 | $374.89M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $188.00M 10-Q · filed 2026-05-11 | $267.85M derived: sum of 2 quarters · filed 2026-05-11 | $344.28M derived: sum of 3 quarters · filed 2026-05-11 | $372.27M derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | $79.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $156.28M derived: sum of 2 quarters · filed 2026-03-02 | $184.27M derived: sum of 3 quarters · filed 2026-03-02 | $188.24M 10-K · filed 2026-03-02 |
| 2025-09-30 | $76.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $104.42M derived: sum of 2 quarters · filed 2025-11-10 | $108.39M 10-Q · filed 2025-11-10 | $112.36M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-06-30 | $27.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $31.96M 10-Q · filed 2025-08-11 | $35.93M derived: sum of 3 quarters · filed 2026-03-02 | $35.11M derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-03-31 | $3.97M 10-Q · filed 2025-05-12 | $7.94M derived: sum of 2 quarters · filed 2026-03-02 | $7.12M derived: sum of 3 quarters · filed 2026-03-02 | $22.51M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.15M derived: sum of 2 quarters · filed 2026-03-02 | $18.54M derived: sum of 3 quarters · filed 2026-03-02 | $34.70M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$820.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $14.57M derived: sum of 2 quarters · filed 2024-11-12 | $30.73M 10-Q · filed 2024-11-12 | $30.73M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | $15.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $31.55M 10-Q · filed 2024-08-09 | $31.55M derived: sum of 3 quarters · filed 2025-03-03 | $31.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | $16.16M 10-Q · filed 2024-05-10 | $16.16M derived: sum of 2 quarters · filed 2025-03-03 | $16.30M derived: sum of 3 quarters · filed 2025-03-03 | $16.45M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $149.00K derived: sum of 2 quarters · filed 2025-03-03 | $299.00K derived: sum of 3 quarters · filed 2025-03-03 | $6.47M 10-K · filed 2025-03-03 |
| 2023-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $299.00K derived: sum of 2 quarters · filed 2023-11-09 | $6.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.32M 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | $6.17M 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $169.25M 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $40.86M 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $30.91M 10-K · filed 2022-03-01 | |||
| 2013-12-31 | $0.00 10-K/A · filed 2014-03-31 | |||
| 2012-12-31 | $2.11M 10-K/A · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |